Literature DB >> 34582787

Revisiting astrocyte to neuron conversion with lineage tracing in vivo.

Lei-Lei Wang1, Carolina Serrano2, Xiaoling Zhong2, Shuaipeng Ma2, Yuhua Zou2, Chun-Li Zhang3.   

Abstract

In vivo cell fate conversions have emerged as potential regeneration-based therapeutics for injury and disease. Recent studies reported that ectopic expression or knockdown of certain factors can convert resident astrocytes into functional neurons with high efficiency, region specificity, and precise connectivity. However, using stringent lineage tracing in the mouse brain, we show that the presumed astrocyte-converted neurons are actually endogenous neurons. AAV-mediated co-expression of NEUROD1 and a reporter specifically and efficiently induces reporter-labeled neurons. However, these neurons cannot be traced retrospectively to quiescent or reactive astrocytes using lineage-mapping strategies. Instead, through a retrograde labeling approach, our results reveal that endogenous neurons are the source for these viral-reporter-labeled neurons. Similarly, despite efficient knockdown of PTBP1 in vivo, genetically traced resident astrocytes were not converted into neurons. Together, our results highlight the requirement of lineage-tracing strategies, which should be broadly applied to studies of cell fate conversions in vivo.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAV; CRISPR-CasRx; DLX2; NEUROD1; PAX6; PTBP1; astrocyte-to-neuron conversion; in vivo reprogramming; lineage tracing; shRNA

Mesh:

Substances:

Year:  2021        PMID: 34582787      PMCID: PMC8526404          DOI: 10.1016/j.cell.2021.09.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  53 in total

1.  Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients.

Authors:  Meng-Lu Liu; Tong Zang; Chun-Li Zhang
Journal:  Cell Rep       Date:  2015-12-24       Impact factor: 9.423

2.  An optimized microRNA backbone for effective single-copy RNAi.

Authors:  Christof Fellmann; Thomas Hoffmann; Vaishali Sridhar; Barbara Hopfgartner; Matthias Muhar; Mareike Roth; Dan Yu Lai; Inês A M Barbosa; Jung Shick Kwon; Yuanzhe Guan; Nishi Sinha; Johannes Zuber
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

3.  Astrocyte-Specific Deletion of Sox2 Promotes Functional Recovery After Traumatic Brain Injury.

Authors:  Chunhai Chen; Xiaoling Zhong; Derek K Smith; Wenjiao Tai; Jianjing Yang; Yuhua Zou; Lei-Lei Wang; Jiahong Sun; Song Qin; Chun-Li Zhang
Journal:  Cereb Cortex       Date:  2019-01-01       Impact factor: 5.357

4.  Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo.

Authors:  Yueguang Liu; Qinglong Miao; Jiacheng Yuan; Su'e Han; Panpan Zhang; Sanlan Li; Zhiping Rao; Wenlong Zhao; Qian Ye; Junlan Geng; Xiaohui Zhang; Leping Cheng
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

5.  Neurod1 regulates survival and formation of connections in mouse ear and brain.

Authors:  Israt Jahan; Jennifer Kersigo; Ning Pan; Bernd Fritzsch
Journal:  Cell Tissue Res       Date:  2010-05-30       Impact factor: 5.249

Review 6.  New approaches for brain repair-from rescue to reprogramming.

Authors:  Roger A Barker; Magdalena Götz; Malin Parmar
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

7.  In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry.

Authors:  Olof Torper; Daniella Rylander Ottosson; Maria Pereira; Shong Lau; Tiago Cardoso; Shane Grealish; Malin Parmar
Journal:  Cell Rep       Date:  2015-07-09       Impact factor: 9.423

8.  A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion.

Authors:  Yu-Chen Chen; Ning-Xin Ma; Zi-Fei Pei; Zheng Wu; Fabricio H Do-Monte; Susan Keefe; Emma Yellin; Miranda S Chen; Jiu-Chao Yin; Grace Lee; Angélica Minier-Toribio; Yi Hu; Yu-Ting Bai; Kathryn Lee; Gregory J Quirk; Gong Chen
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

9.  Environmental impact on direct neuronal reprogramming in vivo in the adult brain.

Authors:  Andrew Grande; Kyoko Sumiyoshi; Alejandro López-Juárez; Jennifer Howard; Bhuvaneswari Sakthivel; Bruce Aronow; Kenneth Campbell; Masato Nakafuku
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Enhancer Analysis Unveils Genetic Interactions between TLX and SOX2 in Neural Stem Cells and In Vivo Reprogramming.

Authors:  Mohammed M Islam; Derek K Smith; Wenze Niu; Sanhua Fang; Nida Iqbal; Guoqiang Sun; Yanhong Shi; Chun-Li Zhang
Journal:  Stem Cell Reports       Date:  2015-11-10       Impact factor: 7.765

View more
  34 in total

Review 1.  Dead Cas(t) light on new life: CRISPRa-mediated reprogramming of somatic cells into neurons.

Authors:  Meiling Zhou; Yu Cao; Ming Sui; Xiji Shu; Feng Wan; Bin Zhang
Journal:  Cell Mol Life Sci       Date:  2022-05-24       Impact factor: 9.261

2.  Lineage tracing: The gold standard to claim direct reprogramming in vivo.

Authors:  Clive N Svendsen; Michael V Sofroniew
Journal:  Mol Ther       Date:  2022-02-04       Impact factor: 11.454

3.  Limited astrocyte-to-neuron conversion in the mouse brain using NeuroD1 overexpression.

Authors:  David Leib; Yong Hong Chen; Alex Mas Monteys; Beverly L Davidson
Journal:  Mol Ther       Date:  2022-02-04       Impact factor: 11.454

Review 4.  The Art of Reprogramming for Regenerative Medicine.

Authors:  Junqi Kuang; Tao Huang; Duanqing Pei
Journal:  Front Cell Dev Biol       Date:  2022-06-30

5.  Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?

Authors:  Huadong Xu; Xu Cheng; Qian Song; Yuxin Yang; Changhe Wang; Xinjiang Kang
Journal:  Neurosci Bull       Date:  2022-02-23       Impact factor: 5.271

Review 6.  Function and therapeutic value of astrocytes in neurological diseases.

Authors:  Hong-Gyun Lee; Michael A Wheeler; Francisco J Quintana
Journal:  Nat Rev Drug Discov       Date:  2022-02-16       Impact factor: 112.288

7.  Reply to In vivo confusion over in vivo conversion.

Authors:  Lei-Lei Wang; Chun-Li Zhang
Journal:  Mol Ther       Date:  2022-02-01       Impact factor: 11.454

8.  In vivo confusion over in vivo conversion.

Authors:  Gong Chen
Journal:  Mol Ther       Date:  2021-10-25       Impact factor: 11.454

9.  Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Weizhao Chen; Qiongping Zheng; Qiaoying Huang; Shanshan Ma; Mingtao Li
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

10.  Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons.

Authors:  Jessica Giehrl-Schwab; Florian Giesert; Benedict Rauser; Chu Lan Lao; Sina Hembach; Sandrine Lefort; Ignacio L Ibarra; Christina Koupourtidou; Malte Daniel Luecken; Dong-Jiunn Jeffery Truong; Judith Fischer-Sternjak; Giacomo Masserdotti; Nilima Prakash; Jovica Ninkovic; Sabine M Hölter; Daniela M Vogt Weisenhorn; Fabian J Theis; Magdalena Götz; Wolfgang Wurst
Journal:  EMBO Mol Med       Date:  2022-04-04       Impact factor: 14.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.